中国药事
中國藥事
중국약사
CHINESE PHARMACEUTICAL AFFAIRS
2015年
6期
571-576
,共6页
战嘉怡%刘春%丁建华%李灿%李蜀平%张体灯%王海南
戰嘉怡%劉春%丁建華%李燦%李蜀平%張體燈%王海南
전가이%류춘%정건화%리찬%리촉평%장체등%왕해남
医疗机构制剂%注册管理%调查研究
醫療機構製劑%註冊管理%調查研究
의료궤구제제%주책관리%조사연구
pharmaceutical preparations in medical institutions%registration management%investigation
目的:了解医疗机构制剂注册管理现状和存在问题,为药品监管部门制定相关政策提供参考。方法:采取问卷调查、实地调研、文献分析、会议座谈、深度访谈等多种形式进行调查。结果:通过调研获得了全国医疗机构制剂注册信息,了解了各省、自治区、直辖市制剂管理的具体方式,征求了省级药品监管部门、医疗机构以及部分名老中医专家对现行制剂管理模式的意见和建议。结论:现行管理模式基本适合我国医疗机构制剂现状,《医疗机构制剂注册管理办法(试行)》的实施有效遏制了制剂批准文号的盲目增加,推动了制剂注册管理水平的提高,但尚有需要完善改进之处。
目的:瞭解醫療機構製劑註冊管理現狀和存在問題,為藥品鑑管部門製定相關政策提供參攷。方法:採取問捲調查、實地調研、文獻分析、會議座談、深度訪談等多種形式進行調查。結果:通過調研穫得瞭全國醫療機構製劑註冊信息,瞭解瞭各省、自治區、直轄市製劑管理的具體方式,徵求瞭省級藥品鑑管部門、醫療機構以及部分名老中醫專傢對現行製劑管理模式的意見和建議。結論:現行管理模式基本適閤我國醫療機構製劑現狀,《醫療機構製劑註冊管理辦法(試行)》的實施有效遏製瞭製劑批準文號的盲目增加,推動瞭製劑註冊管理水平的提高,但尚有需要完善改進之處。
목적:료해의료궤구제제주책관리현상화존재문제,위약품감관부문제정상관정책제공삼고。방법:채취문권조사、실지조연、문헌분석、회의좌담、심도방담등다충형식진행조사。결과:통과조연획득료전국의료궤구제제주책신식,료해료각성、자치구、직할시제제관리적구체방식,정구료성급약품감관부문、의료궤구이급부분명로중의전가대현행제제관리모식적의견화건의。결론:현행관리모식기본괄합아국의료궤구제제현상,《의료궤구제제주책관리판법(시행)》적실시유효알제료제제비준문호적맹목증가,추동료제제주책관리수평적제고,단상유수요완선개진지처。
Objective:To understand the current situation of registration management of pharmaceutical preparations in medical institutions and the existing problems so as to provide references for the drug supervision and administration department to draft relevant policies.Methods:A variety of investigation forms were adopted, such as questionnaire survey, ifeld investigation, literature analysis, meeting and depth interviews. Results:The information of pharmaceutical preparations registration of medical institutions in China was obtained. The speciifc management methods in each province, autonomous region and municipality of China were surveyed. The opinions and suggestions on current management mode were collected from the provincial drug supervision and administration departments, medical institutions and famous traditional Chinese medicine doctors.Conclusion:The current management mode is suitable for the current conditions of pharmaceutical preparations in medical institutions in China. The implementation of Provisions for the Registration of Pharmaceutical Preparations in Medical Institutions (interim) effectively slowed down the growth rate of the new approval number, and improved the level of registration management of pharmaceutical preparations, however, the provisions still need to be perfected.